JBM Sets 22 June 2026 Board Meeting to Approve FY2026 Results and Dividend Proposal

Bulletin Express
06/05

JBM (Healthcare) Limited has scheduled a board meeting for 22 June 2026 to consider and approve the consolidated results for the financial year ended 31 March 2026. The agenda also includes evaluating a potential final dividend and addressing other routine corporate matters.

The notice, dated 5 June 2026, lists the current board composition as follows: Executive Directors—Mr. Sum Kwong Yip, Derek (Chairman and Chief Executive Officer), Mr. Yim Chun Leung and Dr. Cheng Celine Heung Kwan; Non-executive Directors—Mr. Yeung Kwok Chun, Harry and Professor Xu Hongxi; Independent Non-executive Directors—Mr. Chan Kam Chiu, Simon, Mr. Luk Ting Lung, Alan and Mr. Lau Shut Lee, Tony.

The company secretary for the meeting is Mr. Yu Chun Kau.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10